Why you shouldn ’t be happy with $137 insulin

Eli Lilly and Co. recently announced with some fanfare that it was manufacturing a generic version of its own best-selling insulin brand, Humalog, which it would sell for half off — $137.35 versus about $275. David Ricks, the chief executive of Lilly, said the company was making this seemingly beneficent gesture because “many patients are […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.

Source: Kevin, M.D. - Medical Weblog - June 13, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/elisabeth-rosenthal" rel="tag" > Elisabeth Rosenthal, MD < /a > < /span > Tags: Meds Diabetes Endocrinology Source Type: blogs